# A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant

> **NCT00005113** · PHASE3 · TERMINATED · sponsor: **Boston Children's Hospital** · enrollment: 102 (actual)

## Conditions studied

- End-Stage Renal Disease
- Kidney Transplantation

## Interventions

- **DRUG:** Cyclosporine
- **DRUG:** Sirolimus
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT00005113
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-07
- **Primary completion:** 2004-07
- **Final completion:** 2006-03
- **Target enrollment:** 102 (ACTUAL)
- **Why stopped:** Inability to meet the accrual target of 213.
- **Last updated:** 2012-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005113, "A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00005113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*